An International Multi-Center Cohort Study on β-blockers for the Treatment of Symptomatic Children with Catecholaminergic Polymorphic Ventricular Tachycardia

Conclusions: B1-selective BBs were associated with a significantly higher risk for arrhythmic events in symptomatic children with CPVT compared with non-selective BBs, specifically nadolol. Nadolol, or propranolol if nadolol is unavailable, should be the preferred BB for treating symptomatic children with CPVT.PMID:34874747 | DOI:10.1161/CIRCULATIONAHA.121.056018

Source: Circulation - December 7, 2021 Category: Cardiology Authors: Puck J Peltenburg Dania Kallas Johan M Bos Krystien V V Lieve Sonia Franciosi Thomas M Roston Isabelle Denjoy Katrina B Sorensen Seiko Ohno Ferran Roses-Noguer Takeshi Aiba Alice Maltret Martin J LaPage Joseph Atallah John R Giudicessi Sally-Ann B Clur Ni Source Type: research